Background : Normal erythrocyte is deformable and this facilitates blood flow in the capillaries. Oxidative stress reduces the deformability of erythrocytes, and influences on blood flow in microcirculation. The objective of this study was to investigate the deformability of erythrocytes exposed to oxidative stress, the protective effects of verapamil and ascorbic acid against oxidative damages in erythrocytes, and the value of the microfluidic ektacytometer, RheoScan-D (RheoMeditech, Korea) in clinical application.
Methods : Effects of oxidative stress on erythrocytes were investigated using tert-butyl hydroperoxide (tBHP). Before exposure to tBHP, the erythrocytes were pretreated with verapamil and ascorbic acid to examine their protective effect against oxidative damages. The deformability of erythrocytes was measured by the microfluidic ektacytometer, RheoScan-D.
Results : When treated with tBHP, the deformability of erythrocytes was decreased (P<0.01) and methemoglobin (metHb) formation and mean corpuscular volume (MCV) of erythrocytes were increased (P<0.01, P<0.05) compared to those of the untreated control cells. Compared to the tBHP treated cells, pretreatment with verapamil increased the deformability of erythrocytes (P<0.01) and decreased metHb formation (P<0.01) and MCV (P<0.05). Likewise, pretreatment with ascorbic acid increased the deformability of erythrocytes (P<0.01) and decreased metHb formation (P<0.01).
Conclusions : Oxidative stress reduces the deformability of erythrocytes and the deformability could be one of markers for oxidative damage. Verapamil and ascorbic acid have protective role against tBHP induced oxidative stress. The ektacytometer, RheoScan-D used in this study is convenient for clinical measurement and could be used in various fields of clinical medicine. (Fig. 1) . Rheoscan-D는 전단응력 0-30 Pa 범위에서 EI의 값을 모두 구할 수 있지만 (Fig. 2, 3 (Table 1) . (Table 2) .
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MetHb의 평균값은 대조군 4.16에 비하여 tBHP 처리군은 43.45로 유의하게 증가하였으며 tBHP 처리에 앞서 verapamil 과 ascorbic acid를 전 처리한 경우에는 각각 3.64와 3.57로 회 복되었다 (Table 2) . Table 2 . Hematologic changes among non-treated control group, tBHP treated group, verapamil+tBHP treated group, and ascor- 참고문헌
